Anesth Pain Med.  2018 Apr;13(2):176-179. 10.17085/apm.2018.13.2.176.

Dantrolene treatment in a patient with uncontrolled hyperthemia after general anesthesia: a case report of suspected malignant hyperthermia: A case report

• Koh KH
• Park MK
• Choi SU
• Huh H
• Yoon SZ
• Lim CH

• KMID: 2437425
• DOI: http://doi.org/10.17085/apm.2018.13.2.176

Abstract

Fever (body temperature above 38℃) is relatively common during the first few days after general anesthesia. Postoperative fever is usually caused by the inflammation induced by surgery and resolves spontaneously; however, it can be a manifestation of a serious complication such as malignant hyperthermia. We report a case of postoperative hyperthermia (body temperature > 40℃) that was refractory to conventional anti-pyretic measures and finally resolved with dantrolene administration.

Keyword

Dantrolene; Fever; Malignant hyperthermia; Postoperative period

MeSH Terms

Anesthesia, General*
Dantrolene*
Fever
Humans
Inflammation
Malignant Hyperthermia*
Postoperative Period
Dantrolene

Reference

1. Pile JC. Evaluating postoperative fever: a focused approach. Cleve Clin J Med. 2006; 73(Suppl 1):S62–6. DOI: 10.3949/ccjm.73.Suppl_1.S62. PMID: 16570551.

2. Rosenberg H, Davis M, James D, Pollock N, Stowell K. Malignant hyperthermia. Orphanet J Rare Dis. 2007; 2:21. DOI: 10.1186/1750-1172-2-21. PMID: 17456235. PMCID: PMC1867813.

3. MacLennan DH, Duff C, Zorzato F, Fujii J, Phillips M, Korneluk RG, et al. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature. 1990; 343:559–61. DOI: 10.1038/343559a0. PMID: 1967823.

4. Heytens L, Forget P, Scholtès JL, Veyckemans F. The changing face of malignant hyperthermia: less fulminant, more insidious. Anaesth Intensive Care. 2015; 43:506–11. PMID: 26099765.

5. Huh H, Jung JS, Park SJ, Park MK, Lim CH, Yoon SZ. Successful early application of extracorporeal membrane oxygenation to support cardiopulmonary resuscitation for a patient suffering from severe malignant hyperthermia and cardiac arrest: a case report. Korean J Anesthesiol. 2017; 70:345–9. DOI: 10.4097/kjae.2017.70.3.345. PMID: 28580087. PMCID: PMC5453898.

6. Krause T, Gerbershagen MU, Fiege M, Weisshorn R, Wappler F. Dantrolene--a review of its pharmacology, therapeutic use and new developments. Anaesthesia. 2004; 59:364–73. DOI: 10.1111/j.1365-2044.2004.03658.x. PMID: 15023108.

7. Litman RS, Flood CD, Kaplan RF, Kim YL, Tobin JR. Postoperative malignant hyperthermia: an analysis of cases from the North American Malignant Hyperthermia Registry. Anesthesiology. 2008; 109:825–9. DOI: 10.1097/ALN.0b013e31818958e5. PMID: 18946294.

8. Sinha AK, Kumari P, Vaghela MM, Sinha C, Kumar B. Postoperative malignant hyperthermia- a medical emergency: a case report and review of literature. J Clin Diagn Res. 2017; 11:PD01–2. DOI: 10.7860/JCDR/2017/20531.9493.

9. Larach MG, Localio AR, Allen GC, Denborough MA, Ellis FR, Gronert GA, et al. A clinical grading scale to predict malignant hyperthermia susceptibility. Anesthesiology. 1994; 80:771–9. DOI: 10.1097/00000542-199404000-00008. PMID: 8024130.

10. Visoiu M, Young MC, Wieland K, Brandom BW. Anesthetic drugs and onset of malignant hyperthermia. Anesth Analg. 2014; 118:388–96. DOI: 10.1213/ANE.0000000000000062. PMID: 24445637.

11. Brandom BW, Larach MG, Chen MS, Young MC. Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States. Anesth Analg. 2011; 112:1115–23. DOI: 10.1213/ANE.0b013e31820b5f1f. PMID: 21372281. PMCID: PMC3498049.

12. Inada H, Jinno S, Kohase H, Fukayama H, Umino M. Postoperative hyperthermia of unknown origin treated with dantrolene sodium. Anesth Prog. 2005; 52:21–3. DOI: 10.2344/0003-3006(2005)52[21:PHOUOT]2.0.CO;2.

13. Pileggi DJ, Cook AM. Neuroleptic malignant syndrome. Ann Pharmacother. 2016; 50:973–81. DOI: 10.1177/1060028016657553. PMID: 27423483.

14. Grunau BE, Wiens MO, Brubacher JR. Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review. CJEM. 2010; 12:435–42. DOI: 10.1017/S1481803500012598. PMID: 20880437.

15. Hollander AS, Olney RC, Blackett PR, Marshall BA. Fatal malignant hyperthermia-like syndrome with rhabdomyolysis complicating the presentation of diabetes mellitus in adolescent males. Pediatrics. 2003; 111:1447–52. DOI: 10.1542/peds.111.6.1447. PMID: 12777570.